Rouffy J, Jaillard J
Am J Med. 1986 Feb 14;80(2A):100-3. doi: 10.1016/0002-9343(86)90167-1.
To compare the effects of prazosin and atenolol on plasma lipid concentrations, 60 patients with arterial hypertension (diastolic 90 to 120 mm Hg, systolic 160 to 200 mm Hg) were allocated at random to one of two treatment groups. The lipid profile included the determination of total cholesterol and triglyceride levels by ultracentrifugation, and assays of apoproteins A1 and B by laser immunonephelometry. Determinations were performed 30 days before and on the first, 90th, and 180th days of treatment. Both drugs had similar reducing effects on blood pressure. A significant decrease in total cholesterol, low-density lipoprotein cholesterol, and apoprotein B, and an increase in high-density lipoprotein cholesterol and apolipoprotein A1 were observed in patients receiving prazosin, whereas patients receiving atenolol exhibited opposite changes in plasma lipids. Although the clinical significance of these findings is uncertain, such metabolic effects should be taken into account when evaluating the risk/benefit ratio of antihypertensive treatments.
为比较哌唑嗪和阿替洛尔对血脂浓度的影响,将60例动脉高血压患者(舒张压90至120毫米汞柱,收缩压160至200毫米汞柱)随机分配至两个治疗组之一。血脂谱包括通过超速离心法测定总胆固醇和甘油三酯水平,以及通过激光免疫比浊法测定载脂蛋白A1和B。在治疗前30天以及治疗的第1天、第90天和第180天进行测定。两种药物对血压的降低作用相似。接受哌唑嗪治疗的患者总胆固醇、低密度脂蛋白胆固醇和载脂蛋白B显著降低,高密度脂蛋白胆固醇和载脂蛋白A1升高,而接受阿替洛尔治疗的患者血脂出现相反变化。尽管这些发现的临床意义尚不确定,但在评估抗高血压治疗的风险/效益比时应考虑到这种代谢效应。